Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)–Deficient Carcinomas of the Urinary System

MLA

Gupta, Sumati, et al. “Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)–Deficient Carcinomas of the Urinary System.” Clinical Genitourinary Cancer, vol. 16, no. 2, Apr. 2018, pp. e373–82. EBSCOhost, https://doi.org/10.1016/j.clgc.2017.09.001.

APA

Gupta, S., Albertson, D., Gaston, D., Heilbrun, M. E., Agarwal, N., Boucher, K., Parnell, T. J., Liu, T., Morgans, A., Madison, R., Gowen, K., Miller, V. A., Ross, J. S., Ali, S. M., & Millis, S. Z. (2018). Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)–Deficient Carcinomas of the Urinary System. Clinical Genitourinary Cancer, 16(2), e373–e382. https://doi.org/10.1016/j.clgc.2017.09.001

Chicago

Gupta, Sumati, Daniel Albertson, David Gaston, Marta E. Heilbrun, Neeraj Agarwal, Ken Boucher, Timothy J. Parnell, et al. 2018. “Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)–Deficient Carcinomas of the Urinary System.” Clinical Genitourinary Cancer 16 (2): e373–82. doi:10.1016/j.clgc.2017.09.001.